HSR 609

Drug Profile

HSR 609

Latest Information Update: 24 Jan 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Abbott Japan
  • Class Antiallergics; Antiasthmatics; Antihistamines; Benzoxepins; Pyridines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic rhinitis; Urticaria

Most Recent Events

  • 15 Feb 2008 Discontinued - Phase-II for Allergic rhinitis in Japan (PO)
  • 15 Feb 2008 Discontinued - Phase-II for Urticaria in Japan (PO)
  • 23 Sep 2004 No development reported - Phase-II for Allergic rhinitis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top